Kibur Medical Inc’s Post

🦠 Ever thought of fighting cancer with a splash of hydrogen peroxide? Turns out, cancer cells don't like it one bit. 🧪 🗂️ Review explores preclinical successes, underlying mechanisms, and combination therapies that amplify H2O2’s cancer-killing prowess. While challenges like selectivity and delivery remain, the potential for personalized cancer treatments is immense. 🔖 Access the preprint: https://lnkd.in/gjr2xATb 🏷 Peer-reviewed article is out in Cancers MDPI: https://lnkd.in/dJmDzUBS #CancerResearch #HydrogenPeroxide

Ovarian Cancer Research Alliance remains committed to funding innovative research projects, with objectives that include overcoming treatment resistance, developing effective immunotherapies and more. Learn more about this research at bit.ly/3W9AHzd. #OvarianCancer #Immunotherapy #CancerResearch

Dana-Farber Cancer Institute researchers developed a 'G9' CAR, meticulously engineered to precisely target kidney cancer cells with exceptional specificity, binding with high Cell Avidity. By sparing healthy cells, this breakthrough significantly reduces the risk of adverse side effects in clinical settings. This milestone not only demonstrates the efficacy of the G9 CAR but also underscores the significance of evaluating cell-cell interactions using avidity metrics. Check out our latest Labiotech article here: https://bit.ly/3WQF4jg

Fight ovarian cancer smarter with precision medicine! Scientists are unlocking the secrets of ovarian cancer genes, leading to targeted therapies that attack cancer cells more effectively. Early detection is still crucial, so get screened according to your doctor's recommendations. Together, we can make a difference! #OvarianCancerAwarenessMonth #WomensHealth

Fight ovarian cancer smarter with precision medicine! Scientists are unlocking the secrets of ovarian cancer genes, leading to targeted therapies that attack cancer cells more effectively. Early detection is still crucial, so get screened according to your doctor's recommendations. Together, we can make a difference! #OvarianCancerAwarenessMonth #WomensHealth

📺 How to do the FIT bowel cancer screening test: FIT stands for faecal immunochemical test. It looks for tiny traces of blood in the poo which can be a sign of bowel cancer. Find out how to do the test including how to collect the sample and what happens after the test. #bowelcancer #bowelcancerscreening #cancerscreening https://lnkd.in/e9VT24Wi

📺 How to do the FIT bowel cancer screening test: FIT stands for faecal immunochemical test. It looks for tiny traces of blood in the poo which can be a sign of bowel cancer. Find out how to do the test including how to collect the sample and what happens after the test. #bowelcancer #bowelcancerscreening #cancerscreening https://lnkd.in/e9VT24Wi

Please share far and wide: Project Cure CRC!!! "The Colorectal Cancer Alliance (the Alliance) is pleased to announce a Request for Proposals (RFP) for preclinical and clinical translational research with the potential for high impact on diagnosis, treatment, or survivorship of colorectal cancer. Project Cure CRC will prioritize proposals that embrace moving colorectal cancer research to a curative science ASAP. Submitted proposals should focus on projects that are High-Risk/High-Reward and accelerate new therapies and technologies from bench to bedside. Projects that utilize collaborations and/or public-private partnerships are STRONGLY encouraged." Proposals will be accepted for Early-Career Investigator Awards, Senior Investigator Awards, Pilot Awards, Team Science Awards, Opportunistic Awards and Strategic Awards from academic and industry researchers. The Alliance plans to award tens of millions in 2024 for new research and infrastructure needs arising from this RFP.

This is a unique, new CCBIO doctorate work focusing on the patient and healthcare worker perspective on ovarian cancer and not the actual cancer research. Still, cancer biomarker research gives hope and reassurance. https://lnkd.in/dVjsi4dt

At Panavance, we’re focused on advancing cancer treatment with a unique and novel mechanism of action. Our misetionamide (GP-2250) targets cancer cell metabolism by disrupting cancer cell energy pathways restricting growth and proliferation.     Explore the science behind misetionamide to see how we're making strides in #oncology: https://lnkd.in/e2g_RsyP        #PancreaticCancer #OvarianCancer